CALHM2 and Alzheimer disease: In 5×FAD mice harboring five familial AD gene mutations, the conventional knockout (KO) of Calhm2 and the conditional microglial KO of Calhm2 demonstrated a significant decrease in Aβ deposition, neuroinflammation, and cognitive impairments.